A carregar...

Screening for Prostate Cancer: Early Detection or Overdetection?

A sophisticated reading of the randomized trial evidence suggests that, although screening for prostate cancer with prostate-specific antigen (PSA) can reduce cancer-specific mortality, it does so at considerable cost in terms of the number of men who need to be screened, biopsied, and treated to pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vickers, Andrew J., Roobol, Monique J., Lilja, Hans
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415315/
https://ncbi.nlm.nih.gov/pubmed/22053739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1146/annurev-med-050710-134421
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!